Life Sciences IR Focus Solebury's core strength lies in investor relations and corporate communications for life sciences and healthcare. This makes them a strong partner for growth stage or public biotech firms seeking capital, enhanced investor storytelling, and fundraising readiness. Leverage their narrative expertise to translate complex scientific value into investor-friendly messages.

ESG Investor Communications The firm has demonstrated ESG-related capabilities through NYSE collaboration, signaling readiness to lead ESG disclosures, investor education, and media outreach. Target public companies prioritizing ESG to build credibility with investors and analysts; offer ESG reporting, webinar programs, and ongoing IR support.

NYC Mid Market Growth Based in New York with a mid sized team and revenue profile suitable for growth stage and mid market clients, making it a good fit for outsource IR, fundraising strategy, and media relations. Propose scalable retainer programs that align IR activities with capital-raising milestones and investor targeting.

Digital IR Engine Their tech stack shows active use of web analytics, SEO, and content tools that can optimize investor sites, press releases, and investor communications. Cross-sell content marketing, SEO optimization, and analytics services to improve investor engagement and visibility.

Broad Network Advantage With expertise spanning investor relations, equity research, private equity, investment banking and public relations, Solebury can facilitate introductions to investors, bankers, and PE partners. Position as a turnkey fundraising and strategic communications partner capable of supporting financings, M&A communications, and PR campaigns.